Rassy EE - Search Results

1

A prospective clinical study of the implications of IL-8 in the diagnosis, aggressiveness and prognosis of prostate cancer.

Roumeguère T, Legrand F, Rassy EE, Kaitouni MI, Albisinni S, Rousseau A, Vanhaeverbeek M, Rorive S, Decaestecker C, Debeir O, Boudjeltia KZ, Aoun F. Roumeguère T, et al. Among authors: rassy ee. Future Sci OA. 2017 Nov 15;4(2):FSO266. doi: 10.4155/fsoa-2017-0084. eCollection 2018 Feb. Future Sci OA. 2017. PMID: 29379640 Free PMC article.

2

Antibody-Drug Conjugates in Prostate Cancer: Where Are we?

Mjaess G, Aoun F, Rassy E, Diamand R, Albisinni S, Roumeguère T. Mjaess G, et al. Clin Genitourin Cancer. 2023 Feb;21(1):171-174. doi: 10.1016/j.clgc.2022.07.009. Epub 2022 Jul 23. Clin Genitourin Cancer. 2023. PMID: 35999150 Review.

3

Personalized treatment of prostate cancer: better knowledge of the patient, the disease and the medicine.

Aoun F, Rassy EE, Assi T, Kattan J. Aoun F, et al. Among authors: rassy ee. Future Oncol. 2016 Oct;12(20):2359-61. doi: 10.2217/fon-2016-0292. Epub 2016 Jul 18. Future Oncol. 2016. PMID: 27424848 No abstract available.

4

Advances in urothelial bladder cancer immunotherapy, dawn of a new age of treatment.

Aoun F, Rassy EE, Assi T, Albisinni S, Katan J. Aoun F, et al. Among authors: rassy ee. Immunotherapy. 2017 Mar;9(5):451-460. doi: 10.2217/imt-2017-0007. Immunotherapy. 2017. PMID: 28357911 Review.

5

PDL-1/PD1 inhibitors: antibody or antinobody?

Aoun F, Rassy EE, Assi T, Kattan J. Aoun F, et al. Among authors: rassy ee. Future Oncol. 2017 Aug;13(19):1669-1671. doi: 10.2217/fon-2017-0215. Epub 2017 Aug 23. Future Oncol. 2017. PMID: 28831825 No abstract available.

6

The current state of immune checkpoint inhibitors in the first-line treatment of renal cancer.

Rassy EE, Khoury Abboud RM, Ibrahim N, Assi T, Aoun F, Kattan J. Rassy EE, et al. Immunotherapy. 2018 Sep;10(12):1047-1052. doi: 10.2217/imt-2018-0017. Immunotherapy. 2018. PMID: 30185138 Review.

7

A network meta-analysis of the PD(L)-1 inhibitors in the salvage treatment of urothelial bladder cancer.

Rassy EE, Bakouny Z, Aoun F, Haddad FG, Sleilaty G, Assi T, Kattan J. Rassy EE, et al. Immunotherapy. 2018 Jun;10(8):657-663. doi: 10.2217/imt-2017-0190. Epub 2018 Mar 22. Immunotherapy. 2018. PMID: 29562804

8

Is there a role for the platelet-to-lymphocyte ratio in chronic lymphocytic leukemia?

Bakouny Z, Rassy EE, Yared F, Lutfallah AA, Ghosn M, Farhat F, Kattan J. Bakouny Z, et al. Among authors: rassy ee. Future Sci OA. 2018 Oct 5;4(10):FSO344. doi: 10.4155/fsoa-2018-0061. eCollection 2018 Dec. Future Sci OA. 2018. PMID: 30450231 Free PMC article.

9

The management of patients with metastatic prostate cancer during the COVID-19 pandemic.

Assi T, Ibrahim N, K Abboud RM, Kattan C, Rassy E, Nemr E, Kattan J. Assi T, et al. Future Oncol. 2020 Jul;16(20):1455-1461. doi: 10.2217/fon-2020-0361. Epub 2020 May 15. Future Oncol. 2020. PMID: 32412310 Free PMC article.

10

Is blood transfusion safe during the COVID-19 pandemic?

Bassil J, Rassy E, Kattan J. Bassil J, et al. Future Sci OA. 2020 Sep 17;6(9):FSO626. doi: 10.2144/fsoa-2020-0116. Future Sci OA. 2020. PMID: 33230421 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

97 results

Search Page